Anxiolytic-like effects of 4-O-methylhonokiol isolated from Magnolia officinalis through enhancement of GABAergic transmission and chloride influx
- PMID: 21501091
- DOI: 10.1089/jmf.2010.1111
Anxiolytic-like effects of 4-O-methylhonokiol isolated from Magnolia officinalis through enhancement of GABAergic transmission and chloride influx
Abstract
Abstract This study investigated the anxiolytic-like effects of 4-O-methylhonokiol, a neolignan compound of Magnolia officinalis, by using the experimental paradigms of anxiety and compared the results with those of a known anxiolytic, diazepam. A single treatment with 4-O-methylhonokiol (0.1, 0.2, and 0.5 mg/kg, p.o.) or treatment for 7 days (0.5 mg/kg in drinking water) increased the percentage of time spent in the open arms and the number of open arms entries in the elevated plus-maze test. However, the 4-O-methylhonokiol-increased percentage of time spent in the open arm was abolished by treatment with flumazenil, a benzodiazepine receptor antagonist (10 mg/kg). 4-O-Methylhonokiol also increased the number of head dips in the hole-board test, but decreased locomotor activity. Molecular experiments revealed that the α1-subunit of γ-aminobutyric acid (GABA) type A receptors was overexpressed in the cortex of brains of mice after treatment with 4-O-methylhonokiol for 7 days. In addition, 4-O-methylhonokiol also increased chloride influx in cultured cortical cells. It is concluded that 4-O-methylhonokiol may have anxiolytic-like effects and that these effects may be mediated by GABAergic transmission with the increase of Cl(-) channel opening.
Similar articles
-
Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1363-9. doi: 10.1016/j.pnpbp.2007.05.009. Epub 2007 May 26. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17698274
-
Anxiolytic-like effects of sanjoinine A isolated from Zizyphi Spinosi Semen: possible involvement of GABAergic transmission.Pharmacol Biochem Behav. 2009 Apr;92(2):206-13. doi: 10.1016/j.pbb.2008.11.012. Epub 2008 Dec 7. Pharmacol Biochem Behav. 2009. PMID: 19101585
-
Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla.J Ethnopharmacol. 2006 Nov 24;108(2):193-7. doi: 10.1016/j.jep.2006.05.019. Epub 2006 May 26. J Ethnopharmacol. 2006. PMID: 16829000
-
The standardized extract of Loeselia mexicana possesses anxiolytic activity through the γ-amino butyric acid mechanism.J Ethnopharmacol. 2011 Nov 18;138(2):261-7. doi: 10.1016/j.jep.2011.09.010. Epub 2011 Sep 16. J Ethnopharmacol. 2011. PMID: 21979412 Review.
-
Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts.Biomed Pharmacother. 2017 Nov;95:437-446. doi: 10.1016/j.biopha.2017.08.107. Epub 2017 Sep 12. Biomed Pharmacother. 2017. PMID: 28863384 Review.
Cited by
-
Vasorelaxant Activities and its Underlying Mechanisms of Magnolia Volatile Oil on Rat Thoracic Aorta Based on Network Pharmacology.Front Pharmacol. 2022 Feb 28;13:812716. doi: 10.3389/fphar.2022.812716. eCollection 2022. Front Pharmacol. 2022. PMID: 35308213 Free PMC article.
-
Mechanisms of magnoliae cortex on treating sarcopenia explored by GEO gene sequencing data combined with network pharmacology and molecular docking.BMC Genom Data. 2022 Feb 17;23(1):15. doi: 10.1186/s12863-022-01029-x. BMC Genom Data. 2022. PMID: 35176999 Free PMC article.
-
In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors.Molecules. 2023 Jan 27;28(3):1253. doi: 10.3390/molecules28031253. Molecules. 2023. PMID: 36770918 Free PMC article.
-
4'-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.J Neuroinflammation. 2015 May 13;12:89. doi: 10.1186/s12974-015-0307-7. J Neuroinflammation. 2015. PMID: 25962384 Free PMC article.
-
Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.CNS Drugs. 2013 Mar;27(3):207-19. doi: 10.1007/s40263-013-0044-3. CNS Drugs. 2013. PMID: 23436255 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical